Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy

作者: Frédéric-Antoine Dauchy , Sylvie Lawson-Ayayi , Renaud de La Faille , Fabrice Bonnet , Claire Rigothier

DOI: 10.1038/KI.2011.124

关键词: SidaCohortNephrologyInternal medicineRisk factorAtazanavirOdds ratioAcquired immunodeficiency syndrome (AIDS)ImmunologyViral diseaseMedicine

摘要: Abnormal kidney function is common in the course of human immunodeficiency virus (HIV) infection. Here, we performed a cross-sectional analysis using 399 patients within Aquitaine cohort (a hospital-based HIV-1-infected receiving routine clinical management) to estimate prevalence proximal renal tubular dysfunction (PRTD) associated with HIV These did not differ statistically by sociodemographics, median age, years since diagnosis, AIDS stage, or CD4 cell count from entire 3080 patient cohort. Antiretroviral therapy was received 352 patients, 256 given tenofovir (TDF); 325 had undetectable plasma viral load, and 26 were diagnosed PRTD. In multivariate analysis, significant independent associations found between PRTD age (odds ratio (OR) 1.28 per 5-year increase), atazanavir (OR year exposure), TDF 1.23 year) treatment. Among having TDF-containing regimens over period, remained significantly exposure when treatment ongoing 5.22) been discontinued 11.49). Thus, cumulative and/or an increased risk PRTD, concern about its reversibility HIV.

参考文章(46)
Bijvoet Ol, Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate. Clinical Science. ,vol. 37, pp. 23- 36 ,(1969)
M. Laroche, J. F. Boyer, H. Jahafar, J. Allard, I. Tack, Normal FGF23 Levels in Adult Idiopathic Phosphate Diabetes Calcified Tissue International. ,vol. 84, pp. 112- 117 ,(2009) , 10.1007/S00223-008-9204-8
Andy I. Choi, Yongmei Li, Chirag Parikh, Paul A. Volberding, Michael G. Shlipak, Long-term clinical consequences of acute kidney injury in the HIV-infected Kidney International. ,vol. 78, pp. 478- 485 ,(2010) , 10.1038/KI.2010.171
Amanda Mocroft, Ole Kirk, Jose Gatell, Peter Reiss, Panagiotis Gargalianos, Kai Zilmer, Marek Beniowski, Jean-Paul Viard, Schlomo Staszewski, Jens D Lundgren, EuroSIDA Study Group, Chronic renal failure among HIV-1-infected patients AIDS. ,vol. 21, pp. 1119- 1127 ,(2007) , 10.1097/QAD.0B013E3280F774EE
Michael Horberg, Beth Tang, William Towner, Michael Silverberg, Susan Bersoff-Matcha, Leo Hurley, Joseph Chang, Jackie Blank, Charles Quesenberry, Daniel Klein, Impact of Tenofovir on Renal Function in HIV-Infected, Antiretroviral-Naive Patients Journal of Acquired Immune Deficiency Syndromes. ,vol. 53, pp. 62- 69 ,(2010) , 10.1097/QAI.0B013E3181BE6BE2
Rodolphe Thiébaut, Philippe Morlat, Hélène Jacqmin-Gadda, Didier Neau, Patrick Mercié, François Dabis, Geneviève Chêne, Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. AIDS. ,vol. 14, pp. 971- 978 ,(2000) , 10.1097/00002030-200005260-00008
Sonia Rodríguez-Nóvoa, Pablo Labarga, Antonio DʼAvolio, Pablo Barreiro, Marta Albalate, Eugenia Vispo, Carmen Solera, Marco Siccardi, Stefano Bonora, Giovanni Di Perri, Vincent Soriano, Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations. AIDS. ,vol. 24, pp. 1064- 1066 ,(2010) , 10.1097/QAD.0B013E32833202E2
JJ Kiser, ML Carten, CL Aquilante, PL Anderson, P Wolfe, TM King, T Delahunty, LR Bushman, CV Fletcher, The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV‐infected Patients Clinical Pharmacology & Therapeutics. ,vol. 83, pp. 265- 272 ,(2008) , 10.1038/SJ.CLPT.6100269
Jennifer J Kiser, Christina L Aquilante, Peter L Anderson, Tracy M King, Monica L Carten, Courtney V Fletcher, Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients Journal of Acquired Immune Deficiency Syndromes. ,vol. 47, pp. 298- 303 ,(2008) , 10.1097/QAI.0B013E31815E7478